肺炎支原体肺炎并发闭塞性细支气管炎的研究进展

Research progress of Mycoplasma Pneumoniae Pneumonia Superinduced Bronchitis Obiterans

肺炎支原体肺炎是儿童常见社区获得性肺炎之一。近年来,由肺炎支原体肺炎引起的闭塞性细支气管炎有增长趋势,给患儿及其家庭造成心理压力及经济负担。其诊断有赖于临床症状及体征、胸部CT和肺功能的综合评估,其治疗手段目前有大环内酯类药物、糖皮质激素等,但总体预后不良,如能在肺炎支原体急性感染期采取合理有效的手段减少后遗症的发生,可极大地改善患儿的生活质量、减轻家长的心理负担。

Mycoplasma pneumoniae pneumonia is one of the common community acquired pneumonia in children. In recent years, bronchitis obiterans caused by mycoplasma pneumoniae pneumonia has an increasing trend, which causes psychological pressure and financial burden to children and their families. Its diagnose depends on the comprehensive evaluation of clinical symptoms and signs, chest CT and pulmonary function. Currently, its treatment methods are macrolides, glucocorticoids and so on. However, prognosis of this disease is unsatisfactory. If reasonable and effective measures can be taken to reduce the occurrence of sequelae during the acute infection period of Mycoplasma pneumoniae pneumonia, the quality of life of children can be greatly improved and the psychological burden of parents can be reduced.